Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fruchart

Showing results (331-340 of 562) with videos related to

Pageof 57
Sort By:
The American Journal of Medicine|November 27, 1987
Effect of fenofibrate treatment on type III hyperlipoproteinemiaJ C Fruchart, J Davignon, J M Bard, et al.
Progress in Clinical and Biological Research|January 1, 1988
Effect of fenofibrate on apolipoprotein B containing lipoprotein particlesJ C Fruchart, J M Bard, C Fievet, et al.
Lipids|April 3, 1999
Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation on lipoprotein metabolism in the ratG Asset, B Staels, R L Wolff, et al.
The Journal of Clinical Investigation|August 1, 1995
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptorN Vu-Dac, K Schoonjans, V Kosykh, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein compositionJ M Bard, J Dallongeville, E Hagen, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1991
Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activityZ Moussavi, P Depreux, D Lesieur, et al.
Journal of Lipid Research|January 1, 1988
Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptideA Barkia, C Martin, P Puchois, et al.
Lupus|June 24, 2000
Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodiesM Lambert, A Boullier, E Hachulla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Lipoprotein abnormalities in chronic haemodialysis patientsD Parsy, M Dracon, C Cachera, et al.
Thrombosis Research|June 15, 1987
Analysis of phospholipid transfer during HDL binding to platelets using a fluorescent analog of phosphatidylcholineF Martin-Nizard, B Richard, G Torpier, et al.
Pageof 57

Showing results (331-340 of 562) with videos related to

Sort By:
Pageof 57
The American Journal of Medicine|November 27, 1987
Effect of fenofibrate treatment on type III hyperlipoproteinemiaJ C Fruchart, J Davignon, J M Bard, et al.
Progress in Clinical and Biological Research|January 1, 1988
Effect of fenofibrate on apolipoprotein B containing lipoprotein particlesJ C Fruchart, J M Bard, C Fievet, et al.
Lipids|April 3, 1999
Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation on lipoprotein metabolism in the ratG Asset, B Staels, R L Wolff, et al.
The Journal of Clinical Investigation|August 1, 1995
Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptorN Vu-Dac, K Schoonjans, V Kosykh, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein compositionJ M Bard, J Dallongeville, E Hagen, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1991
Pharmacomodulation of 7-(2-methylene-butyryl)-2,3-dihydrobenzoxazin-[1,4]-3-one structure and normolipemic activityZ Moussavi, P Depreux, D Lesieur, et al.
Journal of Lipid Research|January 1, 1988
Enzyme-linked immunosorbent assay for human proapolipoprotein A-I using specific antibodies against synthetic peptideA Barkia, C Martin, P Puchois, et al.
Lupus|June 24, 2000
Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodiesM Lambert, A Boullier, E Hachulla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Lipoprotein abnormalities in chronic haemodialysis patientsD Parsy, M Dracon, C Cachera, et al.
Thrombosis Research|June 15, 1987
Analysis of phospholipid transfer during HDL binding to platelets using a fluorescent analog of phosphatidylcholineF Martin-Nizard, B Richard, G Torpier, et al.
Pageof 57